Tarsus Reports First Quarter 2025 Financial Results and Recent Business Achievements
Provided By GlobeNewswire
Last update: May 1, 2025
Generated $78.3 million in net product sales of XDEMVY®, an increase of 217% year over year and 18% over Q4 2024, and dispensed approximately 72,000 bottles to patients
Read more at globenewswire.com
